Stoke Therapeutics Files 2024 10-K
Ticker: STOK · Form: 10-K · Filed: Mar 18, 2025 · CIK: 1623526
| Field | Detail |
|---|---|
| Company | Stoke Therapeutics, Inc. (STOK) |
| Form Type | 10-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
Stoke Therapeutics filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
Stoke Therapeutics, Inc. filed its 2024 10-K on March 18, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly ASOthera Pharmaceuticals, Inc., is focused on pharmaceutical preparations. Key financial details and operational highlights from the past fiscal year are detailed within the filing, including information on its research and development activities and executive compensation.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Stoke Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Stoke Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 471144582 — IRS Number (Company's IRS identification number)
Key Players & Entities
- Stoke Therapeutics, Inc. (company) — Filer of the 10-K
- ASOthera Pharmaceuticals, Inc. (company) — Former name of Stoke Therapeutics
- 2024-12-31 (date) — Fiscal year end
- 2025-03-18 (date) — Filing date
- 45 WIGGINS AVENUE, BEDFORD, MA 01730 (location) — Company business and mail address
FAQ
What is Stoke Therapeutics' primary business activity?
Stoke Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When did Stoke Therapeutics file its 10-K report?
Stoke Therapeutics filed its 10-K report on March 18, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
What was the former name of Stoke Therapeutics?
The former name of Stoke Therapeutics was ASOthera Pharmaceuticals, Inc., with a name change date of October 28, 2014.
Where is Stoke Therapeutics located?
Stoke Therapeutics is located at 45 Wiggins Avenue, Bedford, MA 01730.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding Stoke Therapeutics, Inc. (STOK).